Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07571928
A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive AzoospermiaMartin Blomberg JensenNot Yet RecruitingPhase 1
NCT07571928Not Yet Recruiting
Phase 1
A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoo...Martin Blomberg Jensen
NCT07571161
Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's DiseaseEli Lilly and CompanyNot Yet RecruitingPhase 3
NCT07571161Not Yet Recruiting
Phase 3
Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired...Eli Lilly and Company
NCT07569224
Testing the Impact of the MOHR Follow-up SupportNational Cancer Institute (NCI)RecruitingNot Applicable
NCT07569224Recruiting
Not Applicable
Testing the Impact of the MOHR Follow-up SupportNational Cancer Institute...
NCT07570914
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver MetastasesTianjin Medical University Cancer Institute and HospitalNot Yet RecruitingPhase 2
NCT07570914Not Yet Recruiting
Phase 2
Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitab...Tianjin Medical Universit...
NCT07571512
In Vitro Microstructural and Mechanical Analysis of Waste Material From Total Knee Arthroplasty for the Study of Innovative Solutions in the Treatment of Joint and Ligament PathologiesStefano ZaffagniniCompleted
NCT07571512Completed
—
In Vitro Microstructural and Mechanical Analysis of Waste Material From Total Kn...Stefano Zaffagnini
NCT07568756
Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer EvaluationBlue Earth DiagnosticsNot Yet RecruitingPhase 2
NCT07568756Not Yet Recruiting
Phase 2
Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Eval...Blue Earth Diagnostics
NCT07569328
Low-dose Colchicine for CABG Graft Failure PreventionBeijing Anzhen HospitalNot Yet RecruitingNot Applicable
NCT07569328Not Yet Recruiting
Not Applicable
Low-dose Colchicine for CABG Graft Failure PreventionBeijing Anzhen Hospital
NCT07571369
Stress Modulation and Dynamic BalanceKafrelsheikh UniversityNot Yet RecruitingNot Applicable
NCT07571369Not Yet Recruiting
Not Applicable
Stress Modulation and Dynamic BalanceKafrelsheikh University
NCT07569939
Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/or Viral TonsillitisUniversity Hospital, Clermont-FerrandNot Yet RecruitingNot Applicable
NCT07569939Not Yet Recruiting
Not Applicable
Evaluation of Treatments for Sore Throat Associated With Acute Pharyngitis and/o...University Hospital, Cler...
NCT07568561
Maternal Methyl-Nutrient Status and Infant Neurodevelopment StudyFar Eastern Memorial HospitalNot Yet Recruiting
NCT07568561Not Yet Recruiting
—
Maternal Methyl-Nutrient Status and Infant Neurodevelopment StudyFar Eastern Memorial Hosp...
NCT07571070
High-Intensity Intermittent Training and Sport-Specific Performance in Youth Amateur BoxersFederal University of VicosaCompletedNot Applicable
NCT07571070Completed
Not Applicable
High-Intensity Intermittent Training and Sport-Specific Performance in Youth Ama...Federal University of Vic...
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07571343
Fueling Labor: Protein Supplementation for Intrapartum Glucose ControlMedical College of WisconsinNot Yet RecruitingNot Applicable
NCT07571343Not Yet Recruiting
Not Applicable
Fueling Labor: Protein Supplementation for Intrapartum Glucose ControlMedical College of Wiscon...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07571616
A Single-Arm Exploratory Study of NatureU Pelvic Health Pumpkin Seed in Women With Urinary Frequency and Leakage SymptomsOmniSolutions Laboratory Holdings LimitedCompletedNot Applicable
NCT07571616Completed
Not Applicable
A Single-Arm Exploratory Study of NatureU Pelvic Health Pumpkin Seed in Women Wi...OmniSolutions Laboratory...
NCT07569094
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital of Guangzhou Medical UniversityNot Yet Recruiting
NCT07569094Not Yet Recruiting
—
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital...
NCT07570186
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy Male ParticipantsOnconic Therapeutics Inc.Not Yet RecruitingPhase 1
NCT07570186Not Yet Recruiting
Phase 1
Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy...Onconic Therapeutics Inc.
NCT07569380
Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only TreatmentRegion VästerbottenNot Yet Recruiting
NCT07569380Not Yet Recruiting
—
Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only TreatmentRegion Västerbotten
NCT07571252
Impact of Preemptive Analgesia on Postoperative Pain in Orthognathic SurgeryUniversity of Puerto RicoNot Yet RecruitingPhase 4
NCT07571252Not Yet Recruiting
Phase 4
Impact of Preemptive Analgesia on Postoperative Pain in Orthognathic SurgeryUniversity of Puerto Rico
NCT07571083
Horizontal Plyometric Training and Sprint Mechanics in Early-Adolescent Track-and-Field AthletesFederal University of VicosaCompletedNot Applicable
NCT07571083Completed
Not Applicable
Horizontal Plyometric Training and Sprint Mechanics in Early-Adolescent Track-an...Federal University of Vic...
Result Breakdown
Not yet recruiting13 (65%)
Completed4 (20%)
Recruiting3 (15%)
not_applicable9 (45%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 12 (10%)
Phase 31 (5%)
Phase 41 (5%)